Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11 -hydroxysteroid dehydrogenase

11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

(2010) R. Ge et al.   CURRENT MEDICINAL CHEMISTRY

11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus

(2010) G. Hollis et al.   DIABETES OBESITY & METABOLISM

Glucocorticoids Differentially Regulate the Expression of CRFR1 and CRFR2α in MIN6 Insulinoma Cells and Rodent Islets

(2010) M. O. Huising et al.   ENDOCRINOLOGY

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

(2010) Daniël H van Raalte et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

(2010) Stuart A Morgan et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Increased pituitary–adrenal activation and shortened gestation in a sample of depressed pregnant women: A pilot study

(2010) V. O'Keane et al.   JOURNAL OF AFFECTIVE DISORDERS

Regulatory mechanism of hypothalamo-pituitary–adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes

(2010) Sun Shin Yi et al.   JOURNAL OF CHEMICAL NEUROANATOMY

Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets

(2010) Barbara Ludwig et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CRFR1 is expressed on pancreatic   cells, promotes   cell proliferation, and potentiates insulin secretion in a glucose-dependent manner

(2009) M. O. Huising et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic β-cells

(2008) Anne-Marie O'Carroll et al.   JOURNAL OF ENDOCRINOLOGY